Boĭko M I
Lik Sprava. 1995 Jan-Feb(1-2):65-7.
A new preparation is reported for treatment of chronic inflammation of the prostate, which substantially lowers rates of patients' complaints and depresses the secretion leucocyte reaction. Prostatilen was shown to be capable of normalization of immunity status of the chronic prostatitis patients thus lowering the microbial index of the cultured prostate secretion microorganisms. The following new nonantibacterial strategy of treatment of chronic prostatitis patients is proposed: prostatilen given as a single agent or in combination with immunomodulators and physiotherapeutic methods. Antibacterial therapy is to be instituted on a short-term basis only during the period of exacerbation of the inflammatory process.
据报道，一种用于治疗前列腺慢性炎症的新制剂，可显著降低患者的不适发生率，并抑制分泌白细胞反应。结果表明，Prostatilen能够使慢性前列腺炎患者的免疫状态正常化，从而降低培养的前列腺分泌物微生物的微生物指数。提出了以下治疗慢性前列腺炎患者的新的非抗菌策略：单独使用Prostatilen或与免疫调节剂及物理治疗方法联合使用。仅在炎症过程加重期间短期进行抗菌治疗。
